GoodRx Holdings, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 41.36M60.37M-293.62M-25.25M-32.83M-8.87M16.39M
Depreciation and Depletion 0.70M1.40M4.00M4.60M4.80M4.50M
Share-based Compensation 1.76M3.75M397.29M160.46M120.23M104.82M99.03M
Deferred Taxes -2.43M-5.67M-10.91M12.85M-0.50M-65.56M-11.91M
Gains from Sales and Divestitures 2.05M2.66M
Gains from Investment Securities 29.49M112.70M-18.11M22.49M17.24M23.62M
Non-cash Items 734.60M341.93M182.60M
Cash from Operations 45.25M83.29M131.34M178.78M146.78M138.29M183.89M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 1.24M3.38M3.39M3.44M3.41M3.38M2.50M
Depreciation & Amortization (CF) 9.81M13.57M18.43M34.54M54.18M107.67M69.54M
Change in Working Capital
Change in Receivables 12.84M14.52M16.14M43.95M-1.38M26.47M2.33M
Change in Account Payables 0.67M0.52M2.15M4.21M-0.87M17.46M-21.24M
Change in Accured Expenses 2.96M11.22M15.01M14.00M-5.27M21.25M25.71M
Other Working Capital Changes 2.63M0.10M40.94M-17.06M13.64M32.16M-6.33M
Investing Activities
Capital Expenditures 2.65M4.32M20.55M29.89M51.25M54.72M69.11M
Acquisitions 31.31M55.79M140.27M156.85M
Divestments 16.58M
Cash from Investing Activities -3.46M-37.05M-91.62M-178.73M-210.50M-55.77M-70.35M
Financing Activities
Other financing activities 25.61M2.21M83.58M57.95M2.67M
Cash from Financing Activities -24.73M-54.78M905.82M-30.53M-120.23M-167.40M-337.50M
Dividend Payments
Dividends Paid - Common 1,346.36M
Additional items
Change in Cash 17.06M-8.55M945.54M-30.48M-183.94M-84.87M-223.95M
Beginning Cash Balance 17.54M34.60M23.15M971.59M941.11M757.16M672.30M
Free Cash Flow 42.60M78.96M110.79M148.89M95.53M83.57M114.78M
Net Cash Flow 17.06M-8.55M945.54M-30.48M-183.94M-84.87M-223.95M